T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.
about
Reduced Paneth cell alpha-defensins in ileal Crohn's diseaseHLA-B27-associated reactive arthritis: pathogenetic and clinical considerationsA chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colonDysbiosis in inflammatory bowel diseaseHuman memory T cells: generation, compartmentalization and homeostasisMechanisms of Natural Tolerance in the IntestineImmune therapy in inflammatory bowel disease and models of colitis.Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.Colonic bacteria express an ulcerative colitis pANCA-related protein epitopeIsolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients.Antibiotics and probiotics in treatment of inflammatory bowel disease.Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.Probiotics and inflammatory bowel disease: is there a scientific rationale?Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody.Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cellsBacteria as the cause of ulcerative colitis.Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation.The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota.Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's diseaseImmunotherapeutic approaches to inflammatory bowel diseases.Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease.New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation.Antimicrobial peptides and gut microbiota in homeostasis and pathology.Infectious agent and immune response characteristics of chronic enterocolitis in captive rhesus macaquesDeficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitisHarnessing regulatory T cells for the treatment of inflammatory bowel disease.Probiotics: The scientific evidence in the context of inflammatory bowel disease.Host-flora interactions in inflammatory bowel disease.Identification and Phylogeny of the First T Cell Epitope Identified from a Human Gut Bacteroides Species.Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host diseaseImmunogenetic phenotypes in inflammatory bowel disease.Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease.Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propriaBiologic targeting in the treatment of inflammatory bowel diseases.Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease.Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome.Innate antimicrobial immunity in inflammatory bowel diseases.
P2860
Q24538724-43193B95-3506-4E3A-B105-FAD6A79C3F53Q24625587-86FF16C0-4A5D-410F-8CAC-59C79DFD8366Q24678661-9BA03CBF-0C91-4A67-BC35-CAC4794EC75AQ24685931-040F0996-8E92-4235-9CAA-49F075FD335DQ26851748-EB097D84-2320-418D-B3E3-F242FBB89FF4Q29031968-838331A1-9ACC-438B-A86A-B5597D59BC0FQ30774968-08ED0BF6-5E49-4B36-94E7-30A361FD6847Q30945619-51E7FD75-0986-4EBD-A5EE-65B8C2AA2800Q31518042-60C2C6F4-6BA8-4537-8869-F93155B5EEB1Q33455780-001F094D-CF9A-47D5-A5DE-3889D037CFA2Q33867934-46D54347-8822-44AC-A4DA-4703BE964A4BQ33894195-21F1A854-AF38-47B5-95A9-576BD5F9B5F3Q33930749-BC137BC0-E83F-48B7-AB6B-413FA511317EQ34009198-6E35E296-952C-4F5A-89E7-D9A5C08D3EEAQ34013041-78DABA83-60B5-40C2-83B6-B99B317B7378Q34104389-1769B78A-3CC4-4935-BF72-08EF965B75C9Q34154684-AE7EAC59-88B5-4196-A09A-71E66DF6A6B3Q34156291-E84E97FF-11D3-4F94-A283-72E3CA81A6B5Q34185576-E3A5D5ED-B153-49E3-8E7A-3FBFC20CE62DQ34451989-06B0CA88-533F-4673-B14B-02A6950CB030Q34813567-3912D34F-89A2-4B90-993C-B6B79640FE14Q34921594-3822F113-E411-40CF-8978-7B11936B3328Q34987870-D9A7A4F4-1EEF-4993-9CB3-57C1E48A3D99Q35106331-D92F5158-1F41-41CA-AA35-1AABE101E43EQ35596664-873F1E98-42AC-4C3E-812F-5FE0C560F360Q35624877-E4D0087D-461E-4AB8-A1E7-6320C018F135Q35637895-BFB7BD30-BE9E-4CA4-81F4-D07653335B41Q35787630-45224C10-7BA5-47A7-94C1-564F01B26D06Q35861128-266203A8-AE8E-4822-916E-BEAF80C08A31Q35993236-7A9F3AC0-F619-425D-ACAD-5048D04184EBQ36058558-AE727C30-4A11-4DBB-8A12-B0AADCBCBAE8Q36506455-7FF91059-3E2B-4DDF-BC5A-A2EC25D42FB1Q37094595-556F7E25-AB88-4D57-A85A-2ABF62C9CA05Q37272092-52F2CBEC-FE79-4B94-B542-4014FEBCC44EQ37288012-D63200EA-716B-4865-8D27-DD635710C465Q37303206-D3180929-5F5A-46AC-9A61-7A0755BE6882Q37419668-896B286D-EF3D-4987-815F-AD2B71419128Q37680981-0D7135C4-FEC5-4AB0-A2BF-FC31E7C5947FQ37682520-D7FA3BC7-4A20-42A4-80BD-2205370B683FQ37786633-9EA33A4F-0C6C-405F-9F41-2F5D943C7CF6
P2860
T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
T cell specificity and cross r ...... nt intestinal flora in humans.
@ast
T cell specificity and cross r ...... nt intestinal flora in humans.
@en
type
label
T cell specificity and cross r ...... nt intestinal flora in humans.
@ast
T cell specificity and cross r ...... nt intestinal flora in humans.
@en
prefLabel
T cell specificity and cross r ...... nt intestinal flora in humans.
@ast
T cell specificity and cross r ...... nt intestinal flora in humans.
@en
P2093
P2860
P356
P1433
P1476
T cell specificity and cross r ...... nt intestinal flora in humans.
@en
P2093
P2860
P304
P356
10.1136/GUT.44.6.812
P407
P577
1999-06-01T00:00:00Z